slides · global inventory
Problem Agitate Solution
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 26,550
Current window 20,851-20,880
Pages 885
Rows per page 30
Arc
20,851-20,880 of 26,550
02
Includes a hub-and-spoke diagram illustrating the effects of pathogenic autoantibodies.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Problem Identification1 hit
06
Red boxes highlight key clinical history metrics: time since diagnosis, splenectomy history, prior therapies, and concurrent therapy usage.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Agitation1 hit
07
The slide uses a hierarchical testing procedure for statistical significance.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Solution1 hit
08
The chart includes error bars and a table of participant counts at the bottom.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Before-After Comparison1 hit
09
The slide uses a stacked bar chart to visualize the response rates and a table to detail specific IWG criteria outcomes.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Comparative Analysis1 hit
14
argenx SE | Results Presentation Deck | 15 slidesargenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Key Takeaways1 hit
01
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Setup1 hit
02
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Setup1 hit
03
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Setup1 hit
04
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Setup1 hit
05
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Setup1 hit
06
Includes a footer with acronym definitions.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Complication1 hit
07
The slide uses a four-column layout to segment strategic focus areas (HER2-high, HR+, gBRCA, TNBC).AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Complication1 hit
08
The slide uses a timeline framework to establish credibility and future-looking innovation.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Complication1 hit
09
The slide uses a horizontal timeline/process flow to map patient treatment stages against therapeutic interventions and resistance mechanisms.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Complication1 hit
10
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
11
The slide uses a process flow diagram to illustrate the randomization of patients into treatment arms.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
12
Includes a table of patients at risk below the x-axis and a summary table of PFS events, median PFS, and hazard ratio.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
13
Standard financial disclosure slide explaining why GAAP reconciliations for projections are not provided.Taboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Resolution1 hit
05
Theravance Biopharma | Investor Conference Presentation Deck | 44 slidesTheravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
06
The slide uses anatomical diagrams to illustrate the spread of alpha-synuclein (labeled 'α') across the nervous system for three different neurodegenerative conditions.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
07
The slide uses a biological process diagram to explain the mechanism of action for midodrine and droxidopa in the context of autonomic disorders.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
08
Includes a screenshot of a BMC Neurology paper and a bar chart showing subgroup analysis of OHSA scores.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
09
The slide uses a biological process diagram to explain how different drugs (agonists, precursors, reuptake inhibitors) affect sympathetic signaling to blood vessels.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
10
The slide uses a biological process diagram to explain the drug's mechanism of action.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
11
The slide uses a process flow diagram to show how patients transition from Study 0169 to 0170.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
14
The chart illustrates a worsening of blood pressure in the placebo group compared to the treatment group.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Before After1 hit
15
The slide uses a bar chart with error bars to show treatment effects. 'Worsening' is indicated by a downward arrow on the right.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Before After1 hit
26
The slide highlights the MSA subgroup with a blue box, suggesting a focus on this specific finding.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · KPI Overview1 hit
27
The slide uses forest plots to compare treatment effects (ampreloxetine vs placebo) across different patient populations (Overall, MSA, PD, PAF).Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · KPI Overview1 hit